Skip to content
Lower risk Drug recall · FDA · Published October 9, 2020

ANI Pharmaceuticals recalls 25mg amphetamine capsules due to incorrect expiration date

ANI Pharmaceuticals recalls 25mg amphetamine capsules with incorrect expiration date (labeled 24 months instead of 18 months). This affects certain prescription bottles manufactured in 2021. Consumers should check their product labels and contact the manufacturer for details.

🇺🇸 FDA recall #D-0047-2021DrugANI Pharmaceuticals ›
Take action

Contact the company

Recalling firmANI Pharmaceuticals, Inc.455 Idc Rd Sw · Baudette, MN 56623-2467
✎ GovInfoNow plain-language explainer

ANI Pharmaceuticals is recalling 25mg amphetamine capsules that were labeled with a 24-month expiration date instead of the correct 16-month expiration date. This labeling error means the product could expire earlier than intended, potentially leading to ineffective medication. Read more at govinfonow.com/recall/36715-ani-pharmaceuticals-recalls-25mg-amphetamine-capsules-due-to-incorrect-expiration.

Source Summary by GovInfoNow · govinfonow.com/recall/36715-ani-pharmaceuticals-recalls-25mg-amphetamine-capsules-due-to-incorrect-expiration · Updated October 4, 2026 · FDA enforcement record: FDA #D-0047-2021

Cite this page

“ANI Pharmaceuticals recalls 25mg amphetamine capsules due to incorrect expiration date.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36715-ani-pharmaceuticals-recalls-25mg-amphetamine-capsules-due-to-incorrect-expiration. Based on FDA recall #D-0047-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0047-2021%22&limit=1).

The FDA announced on Oct. 9, 2020, that ANI Pharmaceuticals voluntarily recalled Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules due to an incorrect expiration date on the label. The product was distributed nationwide in the USA.

How to tell if you have it

  • Brand: ANI Pharmaceuticals
  • Product: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 25 mg, 100-count bottle
  • NDC: 43975-281-10
  • Lot: 19T16
  • Expiration date printed on label: Jan. 2022
  • Quantity: 6780 bottles

The hazard

The product was labeled with a 24-month expiration date instead of the required 18 months, according to the FDA recall record.

Context

GovInfoNow's records show ANI Pharmaceuticals has issued three other recalls since Feb. 15, 2022, including a June 2, 2026 recall of hydrOXYzine oral solution for foreign substances and a May 12, 2026 recall of Estradiol Gel due to defective containers. Other recent recalls of similar products include OurPharma's Sept. 3, 2026 Fentanyl Injection Recall regarding IV bag expiry discrepancy and Kirkman's Feb. 18, 2026 Lidocaine Cream Recall concerning stability issues.

How to tell if you have this one

Check for the product name 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate' on the label. Look for the NDC number 43975-281-10 and the expiration date labeled as January 2022.

  • Brand
    ANI Pharmaceuticals
  • Category
    Drug
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Distributed Nationwide in the USA
  • NDC
    43975-277-10, 43975-278-10, 43975-279-10, 43975-280-10, 43975-282-10, 43975-281-10
Recall numberProduct, codes & lotsQuantity
D-0043-2021Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 5 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-277-10; Lot: 19S07 Exp. Sept. 2021408 bottles
D-0044-2021Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10; Lot: 19S10 Exp. Sept. 2021, 19S11 Exp. Oct. 202113536 bottles
D-0045-2021Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 15 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-279-10; Lot: 19T14 Exp. Dec. 2021, 20D06 Exp. Apr. 202213248 bottles
D-0046-2021Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 20 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-280-10; Lot: 19T15 Exp. Dec. 2021, 20D02, 20D03 Exp. Mar. 202224972 bottles
D-0047-2021Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 25 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-281-10; Lot: 19T16 Exp. Jan. 20226780 bottles
D-0048-2021Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 30 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-282-10; Lot: 19T17 Exp. Dec. 2021, 19T18, 19T19, Exp. Jan. 2022; 20D05 Exp. Apr. 2022; 20D21, Exp. May 202234968 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC number 43975-281-10 and expiration date labeled as January 2022 on the capsule packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Oct 9, 202012. FDA classified it Class III: Oct 21, 202023. Published in FDA’s Enforcement Report: Oct 28, 202034. FDA terminated the recall: Jan 19, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other ANI Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0047-2021 (October 9, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0047-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA